To screen for potential AD therapeutic targets it is important to consider cell states that are disease relevant, so we chose to use mouse BV2 microglia cell lines in which the Psen2 gene is stably knocked down by shRNA (i.e., psen2_kd) along with a control line (i.e., scramble). Here, PSEN2 is linked to Alzheimer disease.